Number of Current Board & Advisor Roles 2
Number of Founded Organizations 2
  • Investor Type  Investment Partner

Andrew Levin is a Managing Director at RA Capital Management. He is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools. Prior to his current position at RA Capital, he was a Vice President at H.I.G. BioVentures and the Director of Pharmaceutical Sciences at the Clinton

Health Access Initiative. He holds a BSE in Mechanical Engineering from Princeton University, a PhD in Biomedical Engineering from the Massachusetts Institute of Technology, and an MD from Harvard Medical School. His graduate thesis investigated specific and general binding in arterial drug delivery.

Number of Current Jobs 2
Number of Past Jobs 1
Andrew Levin has 2 current jobs as Managing Director at RA Capital Management and Co-Founder at Eliem Therapeutics. Additionally, Andrew Levin has had 1 past job as the Vice President at H.I.G. Capital.
Organization Name  
Title At Company  
Start Date  
End Date  
H.I.G. Capital
Vice President2015
Number of Current Board & Advisor Roles 2
Andrew Levin holds 2 board and advisor roles as Board Member at Eliem Therapeutics and Board Observer at Expansion Therapeutics.
Number of News Articles 8
NewsAug 24, 2016
NewsAug 23, 2016
NewsJul 20, 2016
NewsJul 20, 2016
SoCal - Tech — Synthorx Raises $10M
NewsJul 20, 2016